Horm Metab Res 2008; 40(1): 44-49
DOI: 10.1055/s-2007-993218
Animals, Clinical

© Georg Thieme Verlag KG Stuttgart · New York

Prevention of Insulin Resistance by Ingesting Aqueous Extract of Ocimum sanctum to Fructose-fed Rats

S. S. Reddy 1 , R. Karuna 1 , R. Baskar 1 , D. Saralakumari 1
  • 1Department of Biochemistry, Sri Krishnadevaraya University, Anantapur, Andhra Pradesh, India
Further Information

Publication History

received 22.02.2007

accepted 11.07.2007

Publication Date:
18 December 2007 (online)

Abstract

The study was aimed to examine if oral administration of the aqueous extract of the whole plant Ocimum sanctum (OS) protects against the development of insulin resistance in fructose fed rats. Male Wister rats were randomly divided into four groups of eight animals each: group-S (starch diet), group-F (fructose diet), group-F+OS (fructose diet along with Ocimum sanctum extract at a dose of 200 mg/kg), group-S+OS (starch diet along with Ocimum sanctum). During the experimental period of 60 days body weight, plasma glucose, insulin, and triglycerides were measured at an interval of 15 days. Insulin sensitivity was assessed at the end of experimental period by measuring glucose-insulin index, which is the product of the areas under the curve of glucose and insulin during oral glucose tolerance test. The nontoxic nature of OS was revealed by unaltered body weight, plasma glucose, insulin, and triglyceride levels in group-S+OS when compared with group-S. A significant gain in body weight, hyperglycemia, hyperinsulinemia, hypertriglyceridemia, and insulin resistance were observed in group-F when compared with group-S. OS treatment prevented the observed fructose induced alterations in group-F+OS. In conclusion, our results suggests that oral administration of OS aqueous extract could delay the development of insulin resistance in rats and may be used as an adjuvant therapy for treating diabetic patients with insulin resistance.

References

  • 1 Erkelens DW. Insulin resistance syndrome and type 2 diabetes mellitus.  Am J Cardiol. 2001;  88 381-421
  • 2 Kruszynska YT, Olefsky JM. Cellular and molecular mechanisms of non-insulin dependent diabetes mellitus.  J Invest Med. 1996;  44 413-428
  • 3 Hamman RF. Genetic and environmental determinants of non-insulin dependent diabetes mellitus (NIDDM).  Diabetes Metab Rev. 1992;  8 287-338
  • 4 Basciano H, Federico L, Adeli K. Fructose, insulin resistance, and metabolic dyslipidemia.  Nutr Metab. 2005;  2 5
  • 5 Thorburn AW, Storlien LH, Jenkins AB, Khouri S, Kraegen EW. Fructose-induced in vivo insulin resistance and elevated plasma triglyceride levels in rats.  Am J Clin Nutr. 1989;  49 1155-1163
  • 6 Tobey TA, Mondon CE, Zavaroni I, Reaven GM. Mechanism of insulin resistance in fructose-fed rats.  Metabolism. 1982;  31 608-612
  • 7 Zavaroni I, Chen YD, Reaven GM. Studies of the mechanism of fructose-induced hypertriglyceridemia in the rat.  Metabolism. 1982;  31 1077-1083
  • 8 Emilien G, Maloteaux JM, Ponchon M. Pharmacological management of diabetes: recent progress and future perspective in daily drug treatment.  Pharmacol Ther. 1999;  81 37-51
  • 9 Sethi J, Sood S, Seth S, Talwar A. Protective effect of Tulsi (Ocimum Sanctum) on lipid peroxidation in stress induced by anemic hypoxia in rabbits.  Indian J Physiol Pharmacol. 2003;  47 115-119
  • 10 Kelm MA, Nair MG, Strasburg GM, DeWitt DL. Antioxidant and cyclooxygenase inhibitory phenolic compounds from Ocimum sanctum Linn.  Phytomedicine. 2000;  7 7-13
  • 11 Gupta SK, Prakash J, Srivastava S. Validation of traditional claim of Tulsi, Ocimum sanctum Linn. as a medicinal plant.  Indian J Exp Biol. 2002;  40 765-773
  • 12 Kath RK, Gupta RK. Antioxidant activity of hydroalcoholic leaf extract of Ocimum sanctum in animal models of peptic ulcer.  Indian J Physiol Pharmacol. 2006;  50 391-396
  • 13 Sood S, Narang D, Dinda AK, Maulik SK. Chronic oral administration of Ocimum sanctum Linn. augments cardiac endogenous antioxidants and prevents isoproterenol-induced myocardial necrosis.  J Pharm Pharmacol. 2005;  57 127-133
  • 14 Gupta S, Mediratta PK, Singh S, Sharma KK, Shukla R. Antidiabetic, anticholesterolaemic and antioxidant effect of Ocimum sanctum (Linn) seed oil.  Indian J Exp Biol. 2006;  44 300-304
  • 15 Babu K, Uma Maheswari KC. In vivo studies on the effect of Ocimum sanctum L. leaf extract in modifying the genotoxicity induced by chromium and mercury in Allium root meristems.  J Environ Biol. 2006;  27 93-95
  • 16 Sood S, Narang D, Thomas MK, Gupta YK, Maulik SK. Effect of Ocimum Sanctum Linn. On cardiac changes in rats subjected to chronic restraint stress.  J Ethnopharmacol. 2006;  108 423-427
  • 17 Niture SK, Rao US, Srivenugopal KS. Chemoprotective strategies targeting the MGMT repair protein: augmented expression in human lymphocytes and tumor cells by ethanolic and aqueous extracts of several Indian medicinal plants.  Int J Oncol. 2006;  29 1269-1278
  • 18 Gupta SK, Srivastava S, Trivedi D, Joshi S, Halder N. Ocimum sanctum modulates selenite-induced cataractogenic changes and prevents rat lens opacification.  Curr Eye Res. 2005;  30 583-591
  • 19 Singh S, Malhotra M, Majumdar DK. Antibacterial activity of Ocimum sanctum L. fixed oil.  Indian J Exp Biol. 2005;  43 835-837
  • 20 Shetty S, Udupa S, Udupa L, Somayaji N. Wound healing activity of Ocimum sanctum Linn with supportive role of antioxidant enzymes.  Indian J Physiol Pharmacol. 2006;  50 163-168
  • 21 Narendhirakannan RT, Subramanian S, Kandaswamy M. Biochemical evaluation of antidiabetogenic properties of some commonly used Indian plants on streptozotocin-induced diabetes in experimental rats.  Clin Exp Pharmacol Physiol. 2006;  33 1150-1157
  • 22 Chattopadhyay RR. Hypoglycemic effect of Ocimum sanctum leaf extract in normal and streptozotocin diabetic rats.  Indian J Exp Biol. 1993;  31 891-893
  • 23 Vats V, Yadav SP, Grover JK. Ethanolic extract of Ocimum sanctum leaves partially attenuates streptozotocin-induced alterations in glycogen content and carbohydrate metabolism in rats.  J Ethnopharmacol. 2004;  90 155-160
  • 24 Nader R, Paul B, John A. Lipids, Lipoproteins and Apolipoproteins. In: Tietz NW (ed). Text book of clinical chemistry. Philadelphia: Saunders WB 1994: 809-852
  • 25 Reaven GM. Role of insulin resistance in human disease.  Diabetes. 1988;  37 1595-1607
  • 26 Bessesen DH. The role of carbohydrates in insulin resistance.  J Nutr. 2001;  131 S2782-S2786
  • 27 Elliott SS, Keim NL, Sterns JS, Teff K, Havel PJ. Fructose, weight gain, and the insulin resistance syndrome.  Am J Clin Nutr. 2002;  76 911-922
  • 28 Kanarek RB, Orthen-Gambill N. Differential effects of sucrose, fructose and glucose on carbohydrate-induced obesity in rats.  J Nutr. 1982;  112 1546-1554
  • 29 Rizkalla SW, Boillot J, Tricottet V. Effects of chronic dietary fructose with and without copper supplementation on glycemic control, adiposity, insulin binding to adipocytes and glomerular basement membrane thickness in normal rats.  Br J Nutr. 1993;  70 199-209
  • 30 Tordoff MG, Alleva AM. Effect of drinking soda sweetened with aspartame or high-fructose corn syrup on food intake and body weight.  Am J Clin Nutr. 1990;  51 963-969
  • 31 Bhanot S, Mc Neill JH, Bryer-Ash M. Vanadyl sulphate prevents fructose-induced hyperinsulinemia and hypertension in rats.  Hypertension. 1994;  23 308-312
  • 32 Huang YJ, Fang VS, Juan CC, Chou YC, Kwok CF, Ho LT. Amelioration of insulin resistance and hypertension in a fructose-fed rat model with fish oil supplementation.  Metabolism. 1997;  46 1252-1258
  • 33 Hwang IS, Ho H, Hoffiman BB, Reaven GM. Fructose-induced insulin resistance and hypertension in rats.  Hypertension. 1987;  10 512-516
  • 34 Mayes PA. Intermediary metabolism of fructose.  Am J Clin Nutr. 1993;  58 ((Suppl)) 754S-765S
  • 35 Southgate DAT. Digestion and metabolism of sugars.  Am J Clin Nutr. 1995;  62 ((Suppl)) 203S-211S
  • 36 Randle TJ. Regulatory interactions between lipids and carbohydrates: the glucose fatty acid cycle after 35 years.  Diabetes Metab Rev. 1998;  14 263-283
  • 37 Shibasaki M, Bujo H, Takahasi K, Murakami K, Unoki H, Saito Y. Catalytically inactive lipoprotein lipase overexpression increases insulin sensitivity in mice.  Horm Metab Res. 2006;  38 491-496
  • 38 Bessesen DH. The role of carbohydrates in insulin resistance.  J Nutr. 2001;  131 S2782-S2786
  • 39 Vos P de, Lefebvre AM, Miller SG, Guerre-Millo M, Wong K, Saladin R, Hamann LG, Staels B, Briggs MR, Auwerx J. Thiazolidinediones repress ob gene expression in rodents via activation of peroxisome proliferators-activated receptor gamma.  J Clin Invest. 1996;  98 1004-1009

Correspondence

Prof. D. Saralakumari

Department of Biochemistry

Sri Krishnadevaraya University

515 003 Anantapur

Andhra Pradesh

India

Phone: +91/85/54 25 58 79

Fax: +91/85/54 25 58 05

Email: skumari1@yahoo.co.in

    >